The EluNIR™ Ridaforolimus Eluting Coronary Stent System
Raising the Bar on Drug-Eluting Stent Technology
Introducing the EluNIR™ Coronary Stent System, the next generation in drug-eluting stent technology. No other stent combines a unique metallic spring tip with an innovative dual-pattern strut design that advances deliverability in highly complex anatomy for outstanding clinical outcomes.
EluNIR™ is manufactured by Medinol and distributed by Cordis Corporation in certain countries in Europe.
Check with your local Cordis representative or customer service for product availability in your country.

EluNIR™ DES demonstrated outstanding results including a 12 months TLF of 5.4%, TLR of 3.0% and stent thrombosis beyond 30 days of 0.1%.